336 results
Page 5 of 17
6-K
EX-99.1
4qx629jdjke
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
EX-99.1
y39fw
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
EX-99.1
7rxuh im2wb759
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
rfukwweo734uv cvl6k0
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
g4gd26ywxb2vldzsxu
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
132ygxw3vzl088
24 Apr 14
Pride-hd Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
12:00am
6-K
EX-99.1
p4e6ncyl00px
21 Apr 14
Live Filing
12:00am
6-K
EX-99.1
4gaz85xhaad ur
15 Apr 14
Teva Announces Launch of Generic Lunesta® Tablets In the United States
12:00am
6-K
EX-99.1
jw2hrfqmlrubfgfcdi
8 Apr 14
Teva Announces First Approval and Launch of Generic Lovaza®capsules In the United States
12:00am
6-K
EX-99.1
gv8iayag
31 Mar 14
Teva Announces U.s. Supreme Court Will Hear Its Appeal on Copaxone® Patent
12:00am
6-K
EX-99.1
e0kxg0jon7m46yx usp
6 Feb 14
Teva Reports Fourth Quarter and Full Year 2013 Results
12:00am
6-K
EX-99.1
8p5b3kk2ktb5b von
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
7s3vu6 u7s
24 Jan 14
Live Filing
12:00am
6-K
EX-99.1
d0bp5
13 Jan 14
Live Filing
12:00am
6-K
EX-99.1
8adorfjmk975j5zqbo42
9 Jan 14
Teva Names Erez Vigodman as President and CEO
12:00am
6-K
EX-99.1
2jvhv3i3qx
3 Jan 14
Live Filing
12:00am
6-K
EX-99.1
vnbdlwu26r7 qpjm2d9
17 Dec 13
Teva Settles Viagra® Patent Litigation with Pfizer
12:00am
6-K
EX-99.1
oigt2uxq0ul
10 Dec 13
Live Filing
12:00am
6-K
EX-99.1
r5bak 86vmw7uvrg
10 Dec 13
Teva Provides 2014 Non-GAAP Financial Outlook
12:00am